MacroGenics, Inc.
Income Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.8M | $9.1M | $10.7M | $10.4M | $13.1M | $24.5M | $73.1M | $41.7M |
| Cost of Revenue | $176.0K | $270.0K | $163.0K | $85.0K | $258.0K | $113.0K | $116.0K | $3.0M |
| Gross Profit | $10.6M | $8.8M | $10.6M | $10.3M | $12.9M | $24.4M | $73.0M | $38.7M |
| Gross Margin | 98.4% | 97.0% | 98.5% | 99.2% | 98.0% | 99.5% | 99.8% | 92.8% |
| Operating Expenses | ||||||||
| Research & Development | $51.7M | $46.0M | $47.4M | $30.1M | $43.2M | $45.9M | $45.7M | $48.2M |
| SG&A Expense | $14.4M | $14.7M | $12.6M | $12.4M | $13.7M | $13.5M | $13.7M | $15.4M |
| Operating Income | $-58.2M | $-53.8M | $-49.4M | $-35.5M | $-45.0M | $-38.4M | $12.0M | $-25.0M |
| Operating Margin | -538.9% | -590.4% | -460.4% | -341.5% | -342.3% | -156.9% | 16.4% | -59.8% |
| Interest Expense | $6.0K | $1.1M | $0 | $0 | $774.0K | $656.0K | — | $0 |
| Pretax Income | $-55.7M | — | — | — | — | — | — | — |
| Income Tax Expense | $0 | — | — | — | — | — | — | — |
| Net Income | $-55.7M | $-52.2M | $-46.1M | $17.6M | $57.5M | $-38.0M | $12.8M | $-24.8M |
| Net Margin | -515.6% | -573.3% | -429.8% | 168.8% | 437.5% | -155.2% | 17.5% | -59.5% |
| EPS (Basic) | $-0.89 | $-0.84 | $-0.75 | $0.28 | $0.93 | $-0.61 | $0.20 | $-0.40 |
| EPS (Diluted) | $-0.89 | $-0.84 | $-0.74 | $0.28 | $0.92 | $-0.61 | $0.20 | $-0.40 |
| Shares Outstanding (Basic) | 62.7M | 62.3M | 61.9M | 62.0M | 61.9M | 61.8M | 61.4M | 61.5M |
| Shares Outstanding (Diluted) | 62.7M | 62.3M | 61.9M | 62.2M | 62.3M | 61.8M | 61.4M | 61.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |